FT Vest U.S. Equity Max Buffer (APXM) Max Pain Analysis
Max pain is the strike price where aggregate option buyer payout is minimized at expiration. It represents the price at which option writers retain the most premium.
FT Vest U.S. Equity Max Buffer (APXM) operates in the Financial Services sector, specifically the Asset Management industry, with a market capitalization near $20.9M, listed on CBOE, carrying a beta of 0.04 to the broader market. APXM uses FLEX options to match the price returns of SPDR S&P 500 ETF Trust (SPY), up to a predetermined upside cap of at least 7%, while seeking to provide the maximum available buffer of 100% over a one year period starting in April, each year. public since 2025-04-21.
Max pain analysis shows the strike price where the most options expire worthless. No recent options activity for APXM as of 2026-10-16; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.